Envue Medical Inc — Company Profile
NanoVibronix, Inc., operating through its subsidiary NanoVibronix Ltd., develops and commercializes innovative, non-invasive devices that stimulate biological responses for therapeutic purposes. Their core focus areas include mitigating biofilm formation, accelerating wound repair, and alleviating pain. Key among their product line is UroShield, an ultrasound-based solution engineered to deter bacterial colonization and biofilm development in urinary catheters, thereby boosting antibiotic efficacy and reducing associated patient discomfort. They also offer PainShield and WoundShield, both patch-based therapeutic ultrasound technologies. PainShield targets relief from pain, muscle spasms, and joint contractures, while WoundShield is designed to foster tissue regeneration and promote healing in wounds. The company distributes these products directly to consumers and via extensive distributor networks spanning the United States, Israel, Europe, India, and numerous other international regions. Founded in 2003, NanoVibronix, Inc. maintains its corporate headquarters in Elmsford, New York.
- Sector
- Materials
- Industry
- Paper & Forest Products
- Exchange
- UQ
- Headquarters
- TX, US
Key Metrics
- Price
- $0.00
- Market Cap
- $0.00
- Revenue (TTM)
- $0.00
- Net Income (TTM)
- $0.00
- EPS (TTM)
- 0.00
- P/E (TTM)
- 0.00
- P/B (TTM)
- 0.00
- Dividend Yield
- 0.00%
- ROE (TTM)
- 0.00%
- ROA (TTM)
- 0.00%
- Operating Margin
- 0.00%
- Beta
- 0.00
Dividends
- Last Dividend
- $0.00
- Last Yield
- 0.00%
Summary
NanoVibronix, Inc., operating through its subsidiary NanoVibronix Ltd., develops and commercializes innovative, non-invasive devices that stimulate biological responses for therapeutic purposes. Their core focus areas include mitigating biofilm formation, accelerating wound repair, and alleviating pain. Key among their product line is UroShield, an ultrasound-based solution engineered to deter bacterial colonization and biofilm development in urinary catheters, thereby boosting antibiotic efficacy and reducing associated patient discomfort. They also offer PainShield and WoundShield, both patch-based therapeutic ultrasound technologies. PainShield targets relief from pain, muscle spasms, and joint contractures, while WoundShield is designed to foster tissue regeneration and promote healing in wounds. The company distributes these products directly to consumers and via extensive distributor networks spanning the United States, Israel, Europe, India, and numerous other international regions. Founded in 2003, NanoVibronix, Inc. maintains its corporate headquarters in Elmsford, New York.
Ask AI
Mentions in Filings
- May 26, 2026 Doron Besser, M.D. Chief Executive Officer <strong>ENvue Medical, Inc.</strong> 969 Pruitt Avenue Tyler, Texas 77569 Re: ENvue Medical, Inc. Registration Statement on Form S-3 Filed May 18, 2026 File No. 333-296001 Dear Doron Besser, M.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its man …Envue Medical Inc·LETTER - UPLOAD - Filing review upload·26 May·26 May
- May 26, 2026 Doron Besser, M.D. Chief Executive Officer <strong>ENvue Medical, Inc.</strong> 969 Pruitt Avenue Tyler, Texas 77569 Re: ENvue Medical, Inc. Registration Statement on Form S-3 Filed May 18, 2026 File No. 333-296001 Dear Doron Besser, M.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its …Envue Medical Inc·TEXT-EXTRACT - UPLOAD - Filing review upload·26 May·26 May
- … Outset Medical, Inc. | | ECOR | electroCore, Inc. | OSRH | OSR Holdings, Inc. | | EMBC | Embecta Corp. | OSUR | OraSure Technologies, Inc. | | ESTA | Establishment Labs Holdings Inc. | PAVM | PAVmed Inc. | | FEED | <strong>ENVue Medical, Inc.</strong> | PDEX | Pro-Dex, Inc. | | FEMY | Femasys Inc. | PFSA | Processa Pharmaceuticals, Inc. | | FONR | FONAR Corporation | PLSE | Pulse Biosciences, Inc. | | GCTK | GlucoTrack, Inc. | POCI | Precision Optics Corporation, …MERIT MEDICAL SYSTEMS INCEnvue Medical Inc·DEF 14A - Definitive proxy statement·Q2 26·31 Mar
